PDPietro Delva

Pietro Delva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pietro Delva has a total of 17 co-authors. Here are the top co-authors by number of shared publications:

  • Alessandro Lechi

    Department of Biomedical and Surgical Sciences, Section of Medicina Interna C, University of Verona, Verona, Italy

    2 shared publications
  • Enrico Arosio

    Department of Biomedical and Surgical Sciences, Section of Cardiovascular Rehabilitation, University of Verona, Verona, Italy

    2 shared publications
  • Maurizio Degan

    Department of Biomedical and Surgical Sciences, Section of Medicina Interna C, University of Verona, Verona, Italy

    2 shared publications
  • A Lechi

    Department of Biomedical and Surgical Sciences, Section of Medicina Interna C, University of Verona, Policlinico GB Rossi, Piazzale LA Scuro, 37134 Verona, Italy

    1 shared publication
  • A. Lechi

    Department of Biomedical and Surgical Sciences, Section of Medicina Interna C, University of Verona, Verona, Italy

    1 shared publication
  • C. Pastori

    Department of Biomedical and Surgical Sciences, Section of Medicina Interna C, University of Verona, Verona, Italy

    1 shared publication

Latest Publications

  • Endothelial Progenitor Cells in Patients with Severe Peripheral Arterial Disease

    by Pietro Delva, Sergio De Marchi, Manlio Prior, Maurizio Degan, Alessandro Lechi, Maristella Trettene, Enrico Arosio

    The aims of this study were to investigate the interrelationships between endothelial progenitor cells (EPCs), peripheral arterial disease (PAD), and atherosclerotic risk factors, as only limited data are available regarding the EPCs in patients with PAD. The authors studied the number of EPCs by different methods in a carefully selected group of 45 patients with PAD along with 24 healthy subjects (HS). In patients with PAD, by utilizing the dual-binding method, the number of EPCs was significantly increased compared to HS (M ± SD, PAD: 73 ± 33, HS: 52 ± 20 EPCs/high power field; p < .001). On the contrary, both CD34+ cell count and CD133+ cell count were significantly decreased compared to HS. Colony-forming units were significantly increased in PAD compared to HS (median and 25th and 75th percentiles, PAD: 7, 1, 9; HS: 1, 1, 4 CFU/well, respectively; Mann-Whitney, p = .006). In patients with PAD, the number and proliferative activity of circulating EPCs are increased with respect to HS even though EPC count by flourecence-activated cell sorting (FACS) analysis provided different results and this may explain the discrepancy in data collected using different methods. The regulation of the number and biological activity of EPCs in PAD remains unclear.


  • Endothelial progenitor cells in patients with essential hypertension

    by Pietro Delva, Maurizio Degan, Paola Vallerio, Enrico Arosio, Pietro Minuz, Gabriella Amen, Marzia Di Chio, Alessandro Lechi

    Objective(s) The eventual role of blood pressure on the endothelial progenitor cell (EPC) has rarely been evaluated and data collected so far relate to patients with co-existing coronary heart disease. Methods We have studied the number and functional activity of EPC as well as the number of EPC endothelial colony-forming units (CFU) in a carefully selected group of 36 patients with essential hypertension and 24 normotensive control subjects. Results In patients with essential hypertension, the EPC number was not statistically different from that found in control subjects (mean ± SD, essential hypertension 58 ± 29, controls 53 ± 20; EPC/high power field). CFU per well were not statistically different in patients with essential hypertension compared with normotensive controls (mean ± SD, patients with essential hypertension 2.4 ± 2.6, normotensive controls 3 ± 3.3 CFU/well). In essential hypertension patients, the EPC number was inversely correlated with both total (R = 0.635, P < 0.0001) and low-density lipoprotein (LDL)-cholesterol (R = 0.486, P < 0.05). Neither the EPC number nor the EPC CFU were correlated with age, systolic blood pressure, diastolic blood pressure, body mass index, lipoprotein(a), high-sensitivity C-reactive protein or homocysteine. Conclusions The present study shows that essential hypertension is not characterized by the altered number or functional activity of EPC. Plasma total and LDL-cholesterol are independent predictors of reduced numbers of circulating EPC in essential hypertension patients. The absence of any correlation between the characteristics of EPC and several markers predictive of cardiovascular damage merits further investigation.


  • Open Access

    Insulin and glucose mediate opposite intracellular ionized magnesium variations in human lymphocytes

    by P Delva, M Degan, M Trettene, A Lechi

    Insulin is capable of increasing intracellular magnesium, although very little is known about the effect of insulin on the biologically active fraction of magnesium, i.e. the ionized quota (Mgi2+), its interactions with glucose, and the cellular mechanisms involved in these processes. We studied the interactions of the effects of insulin and glucose on intracellular ionized magnesium in human lymphocytes. Mgi2+ was measured using a fluorimetric method and the Mg2+-sensitive dye, furaptra. We found that insulin significantly increases the Mgi2+(without insulin 227 ± 14 μM, with 10 μU/ml, insulin 301 ± 30 μM, Pn = 12) in a dose-dependent manner in all three glucose concentrations tested (5, 7 and 15 mmol/l). The half-maximal effect of insulin was approximately 0.8 μU/ml. Glucose and insulin showed opposite effects in their ability to modify Mgi2+ in lymphocytes. Inhibitors of the membrane Na+- Mg2+ transport system and of phosphatidylinositol (PI) 3-kinase abolish the insulin-mediated increase of Mgi2+, thus suggesting that insulin is capable of increasing Mgi2+ by modulating the activity of this transport system, possibly through the mediation of PI 3-kinase activation. Taking into account the relationship between insulin and glucose plasma levels and their opposing effects on Mgi2+, this mechanism may represent the two limbs of a biphasic regulatory system of Mgi2+ in both physiological and pathological conditions.